Published in Biotech Business Week, July 5th, 2010
"Specifically, GaAs substrates were chemically modified with thiol-derivatized oligonucleotide aptamers following conventional condensed-phase deposition techniques and exposed to the target ATP molecules. The resulting modification in the PL intensity is attributed to a specific biorecognition interaction between the aptamer receptors and the ATP...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.